Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronan Roussel

Showing results (81-90 of 202) with videos related to

Pageof 21
Sort By:
Diabetes Care|December 22, 2016
Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective CohortPierre-Jean Saulnier, Elise Gand, Gilberto Velho, et al.
Journal of Hypertension|December 17, 2016
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studiesFabrice Bonnet, Amalia Gastaldelli, Florence Pihan-Le Bars, et al.
Molecular Metabolism|October 1, 2016
Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profilingLoic Yengo, Abdelilah Arredouani, Michel Marre, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2011
Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected womanKamel Mohammedi, Ronan Roussel, Oussaima El Dbouni, et al.
Cardiovascular Diabetology|November 18, 2022
Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC populationIulia Petria, Samuel Albuquerque, Gaël Varoquaux, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2016
Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the CommunityRonan Roussel, Ray El Boustany, Nadine Bouby, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2014
Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney diseaseRonan Roussel, Léopold Fezeu, Michel Marre, et al.
Diabetologia|February 28, 2019
Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic useLouis Potier, Ronan Roussel, Gilberto Velho, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 16, 2019
Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING StudyJeremy Pettus, Ronan Roussel, Fang Liz Zhou, et al.
Diabetes Care|October 13, 2016
Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 DiabetesGilberto Velho, Ray El Boustany, Guillaume Lefèvre, et al.
Pageof 21

Showing results (81-90 of 202) with videos related to

Sort By:
Pageof 21
Diabetes Care|December 22, 2016
Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective CohortPierre-Jean Saulnier, Elise Gand, Gilberto Velho, et al.
Journal of Hypertension|December 17, 2016
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studiesFabrice Bonnet, Amalia Gastaldelli, Florence Pihan-Le Bars, et al.
Molecular Metabolism|October 1, 2016
Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profilingLoic Yengo, Abdelilah Arredouani, Michel Marre, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2011
Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected womanKamel Mohammedi, Ronan Roussel, Oussaima El Dbouni, et al.
Cardiovascular Diabetology|November 18, 2022
Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC populationIulia Petria, Samuel Albuquerque, Gaël Varoquaux, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2016
Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the CommunityRonan Roussel, Ray El Boustany, Nadine Bouby, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2014
Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney diseaseRonan Roussel, Léopold Fezeu, Michel Marre, et al.
Diabetologia|February 28, 2019
Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic useLouis Potier, Ronan Roussel, Gilberto Velho, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 16, 2019
Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING StudyJeremy Pettus, Ronan Roussel, Fang Liz Zhou, et al.
Diabetes Care|October 13, 2016
Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 DiabetesGilberto Velho, Ray El Boustany, Guillaume Lefèvre, et al.
Pageof 21